The advent of recombinant tissue-type plasminogen activator (t-PA) revolutionized the management of acute ischaemic stroke more than two decades ago, providing a new therapeutic intervention for a devastating neurological disorder (1). The gene discussed is PLAT; the disease is nervous system disorder.